The PBX3 protein was also found to be a critical cofactor of HOXA9 in leukemogenesis, and targeting of the interaction between the two proteins was deemed to be a feasible strategy to treat acute myeloid leukemia with PBX3 gene overexpression [30]. Here, HOXA9 is linked to acute myeloid leukemia.